New study aims to catch lung cancer early in those who Can't afford care
NCT ID NCT03181256
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 45 uninsured current or former heavy smokers to find early signs of lung cancer. Researchers collect samples like sputum, blood, and urine, and perform CT scans to test new detection methods. The goal is to improve early diagnosis in a group that often misses out on screening.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors spot lung cancer earlier in uninsured smokers, leading to better outcomes.
What could go wrong
This is a small, early-stage study focused on collecting data, not testing a treatment. It may not lead to a proven screening method.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232, United States